Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients.
about
Concise Review: Markers for Assessing Human Stem Cell-Derived Implants as β-Cell Replacement in Type 1 Diabetes.Oral Insulin Delivery in a Physiologic Context: Review.Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.Defining Outcomes for β-Cell Replacement Therapy in the Treatment of Diabetes: a Consensus Report on the Igls Criteria from the IPITA/EPITA Opinion Leaders Workshop.Functional Beta Cell Mass from Device-Encapsulated hESC-Derived Pancreatic Endoderm Achieving Metabolic Control.
P2860
Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Minimal functional β-cell mass ...... in type 1 diabetic recipients.
@en
Minimal functional β-cell mass ...... in type 1 diabetic recipients.
@nl
type
label
Minimal functional β-cell mass ...... in type 1 diabetic recipients.
@en
Minimal functional β-cell mass ...... in type 1 diabetic recipients.
@nl
prefLabel
Minimal functional β-cell mass ...... in type 1 diabetic recipients.
@en
Minimal functional β-cell mass ...... in type 1 diabetic recipients.
@nl
P2093
P2860
P50
P356
P1433
P1476
Minimal functional β-cell mass ...... in type 1 diabetic recipients
@en
P2093
Chantal Mathieu
Christophe De Block
Da Hae Lee
Leonard Kaufman
Ursule Van de Velde
Zhidong Ling
P2860
P304
P356
10.2337/DC13-0128
P407
P577
2013-09-16T00:00:00Z